A detailed history of Us Bancorp \De\ transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 603 shares of HCM stock, worth $8,604. This represents 0.0% of its overall portfolio holdings.

Number of Shares
603
Previous 634 4.89%
Holding current value
$8,604
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$16.03 - $20.31 $496 - $629
-31 Reduced 4.89%
603 $11,000
Q1 2024

May 07, 2024

SELL
$12.08 - $18.56 $277 - $426
-23 Reduced 3.5%
634 $10,000
Q4 2023

Feb 09, 2024

SELL
$16.25 - $20.23 $536 - $667
-33 Reduced 4.78%
657 $11,000
Q2 2023

Aug 09, 2023

SELL
$10.78 - $17.73 $1,670 - $2,748
-155 Reduced 18.34%
690 $8,000
Q1 2023

May 09, 2023

SELL
$13.02 - $19.87 $21,613 - $32,984
-1,660 Reduced 66.27%
845 $11,000
Q4 2022

Feb 13, 2023

BUY
$7.65 - $15.51 $76 - $155
10 Added 0.4%
2,505 $37,000
Q3 2022

Oct 27, 2022

SELL
$8.63 - $15.52 $9,423 - $16,947
-1,092 Reduced 30.44%
2,495 $22,000
Q2 2022

Aug 01, 2022

SELL
$8.59 - $20.77 $859 - $2,077
-100 Reduced 2.71%
3,587 $45,000
Q1 2022

May 11, 2022

BUY
$15.52 - $35.65 $41,795 - $96,005
2,693 Added 270.93%
3,687 $70,000
Q4 2021

Feb 11, 2022

SELL
$28.89 - $35.33 $2,715 - $3,321
-94 Reduced 8.64%
994 $35,000
Q3 2021

Nov 10, 2021

SELL
$35.66 - $42.94 $9,913 - $11,937
-278 Reduced 20.35%
1,088 $40,000
Q2 2021

Aug 05, 2021

BUY
$23.7 - $39.27 $592 - $981
25 Added 1.86%
1,366 $54,000
Q1 2021

Apr 28, 2021

BUY
$27.01 - $36.8 $972 - $1,324
36 Added 2.76%
1,341 $38,000
Q3 2020

Nov 10, 2020

BUY
$25.8 - $34.61 $29,179 - $39,143
1,131 Added 650.0%
1,305 $42,000
Q2 2020

Aug 07, 2020

SELL
$17.65 - $28.05 $829 - $1,318
-47 Reduced 21.27%
174 $5,000
Q1 2020

May 13, 2020

BUY
$15.19 - $29.51 $789 - $1,534
52 Added 30.77%
221 $4,000
Q4 2019

Feb 04, 2020

BUY
$17.17 - $25.95 $2,901 - $4,385
169 New
169 $4,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.